CoreCivic Stock Down This: Fund Buys $5M Stake Amid Growth
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
Tracking error shows how far a fund deviates from its benchmark. Here’s a straightforward explanation of causes and implications for returns.
14,431 articlesCoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
In 2024, medicare paid $12.3 billion for a cluster of services that are now facing tighter coverage. This shift could...
Anthropic's Claude outage on March 2, 2026 disrupted AI workflows for thousands of developers and enterprise customer...
VanEck’s macro bottom thesis contends that Bitcoin has formed a long-term floor near $60,000–$70,000, reshaping 2025–...
A quick surge in a mining stock can spark headlines and questions. This guide breaks down the what, why, and how to r...
The Pentagon has formally designated Anthropic as a supply chain risk, a move that could curtail access to defense co...
Imagine a tech titan quietly owning a defense tech unicorn valued at $1B. This piece breaks down the implications for...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Institutional buyers stepped back into Bitcoin, lifting spot ETF inflows and signaling a shift back toward the market...
A JPMorgan-backed ETF focused on global dividend payers has a small asset base and a brief track record. Here’s what ...
Capricor's small-cap biotech story hinges on milestones, cash runway, and clinical progress. This guide breaks down w...
XRP has fallen sharply in recent months. This guide explains the risks and how to decide if down months can become ba...